Salarius Pharmaceuticals, Inc. (SLRX)
Q2 2020 Earnings Conference Call
August 12, 2020, 16:30 ET
Company Participants
David Arthur - CEO, President & Director
Mark Rosenblum - EVP, Finance & CFO
Nadeem Mirza - SVP, Clinical Development
Daniela Santiesteban - Director, Research and Business Development
Conference Call Participants
Aydin Huseynov - The Benchmark Company
Wangzhi Li - Ladenburg Thalmann & Co.
Hunter Diamond - Diamond Equity Research
Patrick Doolan - Old Peak Road
Presentation
Operator
Ladies and gentlemen, thank you for standing by, and welcome to the Salarius Pharmaceutical earnings webcast and conference call. [Operator Instructions].